Investor Type | Firm |
Type of Fund | VC |
Industries | BioTech • AgroTech • CleanTech • HealthTech (& Fitness) • Food & Beverage • Healthcare (& Wellness) • Consumer |
Stages | Seed, Series B, Pre-seed |
Investing | United States • United Kingdom • Middle East |
Investment Range | $100,000 - $5,000,000 |
Investment Sweet Spot | $1,500,000 |
Assets Under Management | $10,000,000 |
Agronomics is a venture capital firm based in the UK, primarily investing in innovative companies within the fields of BioTech, AgroTech, CleanTech, HealthTech and Fitness, Food and Beverage, Healthcare and Wellness, Consumer, among others. With assets under management amounting to 10 million, Agronomics operates with a focus on early to mid-stage investments, engaging in Seed, Series B, and Pre-seed funding rounds. The firm's investment capital ranges from a minimum of 100,000 to a maximum of 5,000,000, with a sweet spot around 1,500,000 for each investment. Their investment thesis centers on promoting sustainable and ethical food production through cellular agriculture, a cutting-edge approach that employs cell culturing and precision fermentation technologies. This methodology enables the manufacturing of agricultural products that aim to sidestep the detrimental effects of traditional animal husbandry on the environment and animal welfare. On their portfolio, Agronomics highlights investments across diverse applications of cellular agriculture, including but not limited to the production of beef, pork, chicken, egg proteins, dairy alternatives through precision fermentation, sustainable palm oil substitutes, and cultivated meats. The company showcases over 20 companies in their portfolio, reflecting a strong commitment to fostering a new industry that offers solutions to meet animal protein demand more sustainably. The investment strategy of Agronomics is built on the premise that viable technologies are emerging with the potential to disrupt traditional food and agricultural production methods, thereby creating significant investment opportunities with the promise of addressing pressing global issues.